New York, NY, United States of America

Pegah Khosravi

This inventor holds 1 USPTO granted patent. Top assignees: Cornell University, Yale University. Active years: 2024.


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Pegah Khosravi: Innovator in Embryo Selection Technology

Introduction

Pegah Khosravi is a notable inventor based in New York, NY (US), recognized for her contributions to the field of reproductive technology. She has developed innovative methods that enhance the selection process of artificially fertilized embryos, aiming to improve the chances of successful pregnancies.

Latest Patents

Khosravi holds a patent for a "System and method for selecting artificially fertilized embryos." This method involves obtaining images of a set of artificially fertilized embryos incubating in an incubator. The morphological quality of these embryos is assessed using a convolutional neural network trained on pre-classified embryo images. Each embryo is graded based on its morphological quality, and a probability of successful pregnancy is computed for each embryo based on its grade and clinical parameters associated with the gestating female. The method ultimately recommends one or more graded embryos for implantation based on the probability of success, tailored to the desired outcome of the gestating female.

Career Highlights

Throughout her career, Pegah Khosravi has worked with prestigious institutions such as Cornell University and Yale University. Her work has significantly impacted the field of reproductive health, particularly in embryo selection technology.

Collaborations

Khosravi has collaborated with notable professionals in her field, including Nikica Zaninovic and Olivier Elemento. These collaborations have furthered her research and development efforts in embryo classification and selection.

Conclusion

Pegah Khosravi's innovative work in embryo selection technology showcases her commitment to advancing reproductive health. Her patented methods have the potential to transform the way embryos are evaluated and selected, ultimately improving outcomes for gestating females.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…